Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03758209
Other study ID # 48931-2/2018/EKU ETT-TUKEB
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 1, 2018
Est. completion date November 1, 2019

Study information

Verified date March 2020
Source St. Borbala Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Elective surgery is the most effective treatment option for colorectal cancer, however it has been recognized to be associated with high morbidity and mortality risks.

ERAS (Enhanced Recovery After Surgery) is a preoperative multimodality treatment package, which has been well investigated and proved to be effective in reducing early postoperative morbidity, mortality, length of hospital stay and hospital costs, as well. Still, a good proportion of patients are not suitable for ERAS program, mainly based on lack of compliance and the impaired physical function before surgery.

Prehabilitation Program is a recently introduced trimodal preoperative preparation (training) program, which addresses improvement of physical, mental and nutritional status of the high risk elective surgery patients.

This study aims to investigate the benefit of all efforts of a 4-6-week preoperative preparation program (Prehabilitation) being added to an established ERAS protocol.


Description:

Aim:

Colorectal cancer patients with a planned resection are tested if a complex, trimodal rehabilitation program can hold functional and morbidity benefit for them.

In the prospective, randomized (1:1) study control patient group will be the well established and tested ERAS (enhanced recovery after surgery) Program.

Study protocol in details:

1. First visit: Outpatient Department of Surgery

On both arms:

• History taking (including family history and oncologic history);

• Physical examination

- Operation indication, type of procedure and date of procedure agreed;

- Organizing further investigations, anesthesia;

- Operative risk assessment ("ACS - surgical risk calculator");

- Study patient identifier Nr generated;

2. Nurse-led ERAS/Prehab clinic: randomization

On both arms:

- Randomization (Prehabilitation Program / ERAS Program).

- Nurse led clinic assessment ("study nurse"):

.i. CaseReportForm (CRF) filled in.

.ii. Patient data (personal data, demographics, history) .iii. Anthropometrics (BMI, MUST, Body fat % measurement). .iv. Mental hygienic status assessment (smoking, alcohol consumption, anxiety, depression, sleeping disorders).

.v. Cardiovascular status (resting HR, RR). .vi. Operative risk assessment (CR-Possum score). .vii. Preoperative counseling (operation type, preparation, pain management, discharge plan).

.viii. Preoperative nutritional planning (education, nutrient prescription). .ix. Alcohol intake and smoking cessation - information given. .x. Stoma education started. .xi. Consent signed, patient workbook handed over. .xii. Respiratory test referral.

3. Physiotherapy, first visit

Both on control and interventional arms:

- Respiratory function test recorded.

- Physical status tested (6MWD) on a treadmill.

Just on Prehabilitation arm:

• Respiratory training education.

- Respiratory trainer device usage educated.

- Daily activity (walking) planned.

4. Physiotherapy - second/third/fourth visit (weekly)

Just on Prehabilitation arm:

• Previous week activity reviewed as to workbook.

• Physical assessment: 6MWD, FVC.

• Next week activity planned.

5. Psychic preparation

Just on Prehabilitation arm:

- Once a week half an hour group relaxation training - regardless of the stage of prehabilitation program.

6. Admission to the Surgical Ward a day before surgery

Both on control and interventional arm:

- Preoperative assessment:

.i. Anthropometrics (BMI, body fat%). .ii. Cardiovascular stage (resting HR and RR), ECG. .iii. Respiratory function tests. .iv. Physical status (6MWD) .v. Mental status (Hospital Anxiety and Depression Scale (HADS)) assessment.

- Preoperative preparation (as to ERAS protocol).

- Postoperative care (ITU, pain management, mobilization, oral nutrition built up, drains early removal, complications recorded (Clavien-Dindo-classification)).

- Stoma education.

- Dietary education.

- On discharge: Quality of Life (QoL) SF36 - (36-Item Short Form Survey from the RAND Medical Outcomes Study).

7. Postoperative follow up:

Both on control and interventional arms:

• Assessment (4th and 8th week post op.):

.i. Anthropometrics (BMI, Body fat %) .ii. Cardiovascular status (resting HR and RR). .iii. Respiratory function tests. .iv. Physical status (6MWD).


Recruitment information / eligibility

Status Completed
Enrollment 184
Est. completion date November 1, 2019
Est. primary completion date November 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patient with histologically proven primary colorectal adenocarcinoma

- any stage of colorectal cancer

- elective operation

- curative intention

- informed consent signed by patient

Exclusion Criteria:

- emergency operation

- palliative operation

- non-colorectal, second malignancy

- pregnancy

- patient not giving consent

Study Design


Intervention

Procedure:
Prehabilitation + ERAS
Prehabilitation will cover a range preoperative education and exercises (weekly) on diet, physical activity (daily walking), respiratory training (forced deep inspiration with spirometer device), as well as anxiolytic group psychotherapy.
ERAS
Enhanced Recovery Program, including preoperative 4 weeks nutritional supplementation.

Locations

Country Name City State
Hungary Department of Surgery, St. Borbala Hospital Tatabánya

Sponsors (3)

Lead Sponsor Collaborator
St. Borbala Hospital Semmelweis University, St. Borbala Hospital, Department of Surgery

Country where clinical trial is conducted

Hungary, 

References & Publications (5)

Bánky B, Lakatos M, Varga K, Hansági E, Horváth É, Járay G. [Enhanced Recovery Program in colorectal surgery]. Magy Seb. 2018 Mar;71(1):3-11. doi: 10.1556/1046.71.2018.1.1. Hungarian. — View Citation

Bousquet-Dion G, Awasthi R, Loiselle SÈ, Minnella EM, Agnihotram RV, Bergdahl A, Carli F, Scheede-Bergdahl C. Evaluation of supervised multimodal prehabilitation programme in cancer patients undergoing colorectal resection: a randomized control trial. Acta Oncol. 2018 Jun;57(6):849-859. doi: 10.1080/0284186X.2017.1423180. Epub 2018 Jan 12. — View Citation

Carli F, Silver JK, Feldman LS, McKee A, Gilman S, Gillis C, Scheede-Bergdahl C, Gamsa A, Stout N, Hirsch B. Surgical Prehabilitation in Patients with Cancer: State-of-the-Science and Recommendations for Future Research from a Panel of Subject Matter Experts. Phys Med Rehabil Clin N Am. 2017 Feb;28(1):49-64. doi: 10.1016/j.pmr.2016.09.002. Review. — View Citation

Chen BP, Awasthi R, Sweet SN, Minnella EM, Bergdahl A, Santa Mina D, Carli F, Scheede-Bergdahl C. Four-week prehabilitation program is sufficient to modify exercise behaviors and improve preoperative functional walking capacity in patients with colorectal cancer. Support Care Cancer. 2017 Jan;25(1):33-40. Epub 2016 Aug 18. — View Citation

Souwer ETD, Bastiaannet E, de Bruijn S, Breugom AJ, van den Bos F, Portielje JEA, Dekker JWT. Comprehensive multidisciplinary care program for elderly colorectal cancer patients: "From prehabilitation to independence". Eur J Surg Oncol. 2018 Dec;44(12):1894-1900. doi: 10.1016/j.ejso.2018.08.028. Epub 2018 Sep 8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Length of hospital stay Postoperative length of hospital stay in days. within 45 days
Primary Number of days spent on ICU (Intensive care unit). Number of days observed on ICU right after operation. within 45 days postoperative
Primary Morbidity (early) classified after Clavien-Dindo. 7-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed. 7 days (until 8th postoperative day) postoperative
Primary Morbidity (long term) classified after Clavien-Dindo. 30-day morbidity will be detailed assessed. Grade 3 or above morbidity rate will be assessed. 30 days (until 31st postoperative day)
Primary 30-day mortality 30-day mortality of each patient will be recorded. 30 days postoperative
Primary 90-day mortality 90-day mortality of each patient will be recorded. 90 days postoperative
Primary Change in preoperative functional status - 6MWD by operation 6MWD (6-minute walking distance test) Measured points: 4 weeks before surgery, on day of hospital admission
Primary Change in postoperative functional status - 6MWD by the end of rehabilitation 6MWD (6-minute walking distance test) Measured points: 4 weeks before surgery, 8 weeks after operation
Primary Change in preoperative functional status - FVC by operation FVC (forced vital capacity) will be measured. Measured points: 4 weeks before surgery, on day of hospital admission
Primary Change in preoperative functional status - FVC by the end of rehabilitation FVC (forced vital capacity) will be measured. Measured points: 4 weeks before surgery, 8 weeks after operation
Secondary Delay in beginning of adjuvant oncotherapy (chemotherapy, radiotherapy). Sufficient recovery time until fitness of adjuvant chemo/radiotherapy will be recorded. within 8 weeks, if adjuvant oncotherapy is needed
See also
  Status Clinical Trial Phase
Suspended NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Not yet recruiting NCT05775146 - SBRT of Metastases Following Neo-adjuvant Treatment for Colorectal Cancer With Synchronous Liver Metastases Phase 2
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1